Insights into Regulators of p53 Acetylation
Open accessThe DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 is a transcription factor that regulates the expression of dozens of target genes and diverse physiological processes. To precisely regulate the p53 network, p53 undergoes various post-translational modifications and alters the selectivity of target genes. Acetylation plays an essential role in cell fate determination through the activation of p53. Although the acetylation of p53 has been examined, the underlying regulatory mechanisms remain unclear and, thus, have attracted the interest of researchers. We herein discuss the role of acetylation in the p53 pathway, with a focus on p53 acetyltransferases and deacetylases. We also review recent findings on the regulators of these enzymes to understand the mode of p53 acetylation from a broader perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“13 known acetylation sites on p53 are attributable to the activity of at least six different KATs and KDACs [44,45].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052 · cited 1×
“response element-binding protein, respectively [21,22].”
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Cited by
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 107
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Kretová, M., Selicky, T., Čipáková, I., & Čipák, L. (2023) · Life · doi:10.3390/life13030604 · Cited by 46
Mechanisms of Interaction between Enhancers and Promoters in Three Drosophila Model Systems
Kyrchanova, O., Sokolov, V. V., & Georgiev, P. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032855 · Cited by 32
The role of lysine acetylation in metabolic sensing and proteostasis
Eftekhari, A., Sabir, U., & Kasumov, T. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108908 · Cited by 34
The Role of P53 in Myocardial Ischemia-Reperfusion Injury
Zhu, X.-Z., Qiu, Z., Lei, S., Leng, Y., Li, W., & Xia, Z. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07480-x · Cited by 29
Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors
Pękul, M., Szczepaniak, M., Kober, P., Rusetska, N., Mossakowska, B. J., Baluszek, S., Kowalik, A., Maksymowicz, M., Zieliński, G., Kunicki, J., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1302667 · Cited by 24
Targeting CBP and p300: Emerging Anticancer Agents
Masci, D., Puxeddu, M., Silvestri, R., & Regina, G. L. (2024) · Molecules · doi:10.3390/molecules29194524 · Cited by 27
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
Wang, Y., Hu, S., Zhang, W., Zhang, B.-F., & Yang, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01730-5 · Cited by 22
The Role of MicroRNA in the Pathogenesis of Acute Kidney Injury
Bakinowska, E., Kiełbowski, K., & Pawlik, A. (2024) · Cells · doi:10.3390/cells13181559 · Cited by 16
Histone acetylation regulated by histone deacetylases during spermatogenesis
Ou, X., Yang, J., Yang, L., Zeng, H., & Shao, L. (2024) · Andrology · doi:10.1111/andr.13723 · Cited by 12
Neagu, A.-N., Josan, C.-L., Jayaweera, T. M., Morrissiey, H., Johnson, K. R., & Darie, C. C. (2024) · Molecules · doi:10.3390/molecules29174156 · Cited by 15
Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations
Nguyen, H. C., Frisbee, J. C., & Singh, K. K. (2024) · Hearts · doi:10.3390/hearts5010005 · Cited by 11
Zhang, Y., Zhang, G., Wang, Y., Ye, L., Peng, L., Shi, R., Guo, S., He, J., Yang, H., & Dai, Q. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1324859 · Cited by 10
Ramadan, W. S. H., Ahmed, S. B. M., Talaat, I. M., Lozon, L., Mouffak, S., Gemoll, T., Mansour, W. Y., & El‐Awady, R. (2025) · Genome biology · doi:10.1186/s13059-025-03528-3 · Cited by 8
Xu, Y.-F., Yang, N., Hao, P.-H., Wen, R., & Zhang, T. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00773-z · Cited by 14
Roussel-Simonin, C., Fernández-Martínez, A., Postel-Vinay, S. C., Mosele, F., Viansone, A. A., Massard, C., Mouren, A., Vibert, J., & Pistilli, B. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00858-0 · Cited by 9
Silonov, S. A., Mokin, Y. I., Nedelyaev, E. M., Smirnov, E. Y., Константинович, Т. К., Константинович, Т. К., Uversky, V. N., & Fonin, A. V. (2023) · Biomolecules · doi:10.3390/biom13121805 · Cited by 7
Wang, Y., Wang, C., Gong, Y., Li, Q., Liu, M., & Sun, H. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10074-y · Cited by 5
Zhao, Q., He, W., Liu, Z., Huang, L., Yang, X., Liu, Y., Chen, R., Min, X., & Yang, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01709-2 · Cited by 5
Hirayama, M., Yamada, E., Aoki, H., Izumi, K., Amano, A., Toriuchi, K., Ogami, K., Nagasaka, M., Inoue, Y., Hayashi, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-06922-w · Cited by 4
Self-citationWang, Q., Zhang, X., & Xi, L. (2025) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-166600 · Cited by 3
Basha, N. J., & Mohan, R. M. (2024) · ChemistrySelect · doi:10.1002/slct.202304525 · Cited by 4
FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis
Cheng, Y. W., Jiao, Y., Wei, W., Kou, M., Cai, Y., Li, Y., Li, H., & Liu, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1509665 · Cited by 9
Honin, I., Sun, T., Setia, N., Schäker‐Hübner, L., & Hansen, F. K. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00562 · Cited by 3
Wen, J., Liang, Y., Mo, L., Sun, W., Qin, Y., Yue, H., & Zhu, H. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119504 · Cited by 2
Ho, K., Lin, Y., Huang, H.-C., Lai, F.-R., Yang, Y., Lai, C.-H., Wen, Y., Hsieh, F.-K., Lee, W.-J., & Chien, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103945 · Cited by 4
Zenz, T., Jenke, R., Oliinyk, D., Noske, S., Thieme, R., Kahl, T., Gockel, I., Meier-Rosar, F., Aigner, A. M., & Büch, T. (2025) · Neoplasia · doi:10.1016/j.neo.2024.101121 · Cited by 2
Ubiquitin E3 Ligases and p53 in Doxorubicin-Induced Cardiotoxicity
Tachibana, S., Otaki, Y., Goto, J., Watanabe, T., & Watanabe, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110252 · Cited by 2
Liang, J., Li, Z., Jin, L., Wang, Y., Luo, X., Li, X., Zhong, H., Du, D., Luo, C., & Xiong, H. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08271 · Cited by 4
Wu, J., Chen, Y., He, J., Mei, J., Zhu, H., & Zhou, D. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01946-5 · Cited by 2
Luo, C., Wen, B., Liu, J., & Yang, W. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.240077 · Cited by 1
Cancers modulate p53 truncal neoantigen display to evade T cell detectionPreprint
Haratani, K., Reinhold, B. B., Duke‐Cohan, J. S., Fahey, C. G., Tan, K., Mallis, R. J., Gusev, A., Kehl, K. L., Luo, J., Holliday, E. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690562
Identification of MKRN1 as a key modulator of the p53-MDM2 feedback loop
Shimada, T., Noguchi, T., Komatsu, R., Otani, K., Komatsu, T., Suzuki, S., Mitsuya, M., Okubo, T., Ito, R., Yamada, M., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01662-4
Luo, X., Liu, J., Zhang, C., Yuan, W., & Qin, G. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02091-3
Hu, Q.-X., Ou, X., Huang, Y.-Q., Qin, J., Liu, J., Zhang, T.-T., Yan, X., Liang, X., Huang, W., & Hu, K. (2026) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-026-3945-y
Benedetti, R., Crosta, M. D., Stirparo, A., Aron, G. A., Mardente, S., Santarelli, R., Gonnella, R., Montani, M. S. G., & Cirone, M. (2026) · Viruses · doi:10.3390/v18040409
Lu, X. F., Zhang, Y. N., Song, S., Wang, Q., Yang, H., & Li, X. (2026) · Glycoscience & Therapy · doi:10.1016/j.glycos.2026.100049
Zhang, Q.-Q., Yu, C.-Z., Yu, F.-H., Wang, Y.-B., Chen, S., Chen, Z. K., Zhang, W.-J., & Chang, S. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10202-2
Song, T.-X., Rong, Y., Ji, H.-M., & Wang, X.-S. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i6.118497
Post-translational modifications in glioma immune evasion and immunotherapy resistance
Wei, W., 轩玉琴, Cheng, L., & Dai, Q. (2026) · Discover Oncology · doi:10.1007/s12672-026-05592-y
Gampala, S., Li, X., Trejo, J. B., Gritsenko, M., Chu, R., Qian, W., Potchanant, E. A. S., Fishel, M. L., Zhang, T., & Kelley, M. R. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7345898
Kang, N., Zhang, Q., Zhang, X., Cheng, W., Gao, Z., Bao, T., & Zhao, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1890366
Metadata
- Authors
- Nagasaka, M., Miyajima, C., Aoki, H., Aoyama, M., Morishita, D., Inoue, Y., & Hayashi, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Inoue, Yasumichi
- Hayashi, Hidetoshi
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-11-29
- Volume
- 11
- Issue
- 23
- Pages
- 3825
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9737083
- OpenAlex
- W4310474581
- Cited by
- 45
- References
- 189
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 10 · 2023: 7
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grants-in-Aid for Scientific Research (C) (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Grant-in-Aid for Scientific Research (B) (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Grant-in-Aid for Young Scientists (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Grants-in-Aid for Research (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Japan Science and Technology Agency (JST) SPRING (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- p53, protein acetylation, acetyltransferase, deacetylase, post-translational modification, tumor suppressor, p53 target genes, cell fate determination
- MeSH terms
- Acetylation, Acetyltransferases, Protein Processing, Post-Translational, Transcription Factors, Tumor Suppressor Protein p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.